Skip to main content

Table 3 Proportion of patients achieving HbA1c less than 7%

From: Liraglutide and Dulaglutide therapy in addition to SGLT-2 inhibitor and metformin treatment in Indian type 2 diabetics: a real world retrospective observational study

 

Follow-up A1c < 7%

Total

p (2-sided)

No

Yes

Cohort

Dulaglutide

Number of Patients

21

9

30

0.019

%

70.0%

30.0%

100.0%

Liraglutide

Number of Patients

11

19

30

%

36.7%

63.3%

100.0%

Total

Number of Patients

32

28

60

%

53.3%

46.7%

100.0%